High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents.

dc.contributor.author

Goller, Carlos C

dc.contributor.author

Seed, Patrick C

dc.coverage.spatial

United States

dc.date.accessioned

2011-06-21T17:31:32Z

dc.date.issued

2010-07-19

dc.description.abstract

Rising antibiotic resistance among Escherichia coli, the leading cause of urinary tract infections (UTIs), has placed a new focus on molecular pathogenesis studies, aiming to identify new therapeutic targets. Anti-virulence agents are attractive as chemotherapeutics to attenuate an organism during disease but not necessarily during benign commensalism, thus decreasing the stress on beneficial microbial communities and lessening the emergence of resistance. We and others have demonstrated that the K antigen capsule of E. coli is a preeminent virulence determinant during UTI and more invasive diseases. Components of assembly and export are highly conserved among the major K antigen capsular types associated with UTI-causing E. coli and are distinct from the capsule biogenesis machinery of many commensal E. coli, making these attractive therapeutic targets. We conducted a screen for anti-capsular small molecules and identified an agent designated "C7" that blocks the production of K1 and K5 capsules, unrelated polysaccharide types among the Group 2-3 capsules. Herein lies proof-of-concept that this screen may be implemented with larger chemical libraries to identify second-generation small-molecule inhibitors of capsule biogenesis. These inhibitors will lead to a better understanding of capsule biogenesis and may represent a new class of therapeutics.

dc.description.version

Version of Record

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/20657847

dc.identifier.eissn

1932-6203

dc.identifier.uri

https://hdl.handle.net/10161/4554

dc.language

eng

dc.language.iso

en_US

dc.publisher

Public Library of Science (PLoS)

dc.relation.ispartof

PLoS One

dc.relation.isversionof

10.1371/journal.pone.0011642

dc.relation.journal

Plos One

dc.subject

Anti-Bacterial Agents

dc.subject

Antigens, Bacterial

dc.subject

Antigens, Surface

dc.subject

Bacterial Capsules

dc.subject

Escherichia coli

dc.subject

Humans

dc.subject

Virulence

dc.title

High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents.

dc.title.alternative
dc.type

Journal article

duke.date.pubdate

2010-7-19

duke.description.issue

7

duke.description.volume

5

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/20657847

pubs.begin-page

e11642

pubs.issue

7

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Molecular Genetics and Microbiology

pubs.organisational-group

Pediatrics

pubs.organisational-group

Pediatrics, Infectious Diseases

pubs.organisational-group

School of Medicine

pubs.organisational-group

Surgery

pubs.organisational-group

Surgery, Urology

pubs.publication-status

Published online

pubs.volume

5

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
280065600008.pdf
Size:
512.06 KB
Format:
Adobe Portable Document Format